Isoptin Retard

Verapamil Hydrochloride, the active ingredient in Isoptin Retard, is a calcium‑channel blocker presented as a prolonged‑release oral tablet for oral use. It is employed to lower high blood pressure, relieve angina pectoris, and control certain cardiac arrhythmias in adult patients.

GNH USA supplies Isoptin Retard as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for each batch, and customers receive dedicated technical support and can request customized packaging to meet local market requirements.

Isoptin Retard (verapamil) is used in cardiovascular conditions that involve excessive cardiac contractility or vascular tone. - Hypertension: reduces systolic and diastolic blood pressure by vasodilation. - Angina pectoris: decreases myocardial oxygen demand and improves coronary blood flow. - Supraventricular tachycardia: slows atrioventricular conduction to control heart rate.

Verapamil may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Dizziness: transient light‑headedness, especially after standing. - Headache: mild to moderate pressure sensation. - Peripheral edema: swelling of ankles or feet due to vasodilation. - Nausea: upset stomach, sometimes with mild vomiting. - Flushing: warm sensation and reddening of skin. - Fatigue: feeling of tiredness. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Bradycardia: abnormally slow heart rate requiring medical attention. - Heart block: impaired electrical conduction that may need a pacemaker. - Severe hypotension: sudden drop in blood pressure causing fainting. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Allergic reactions: rash, itching, or anaphylaxis in rare cases. - Pulmonary edema: fluid accumulation in the lungs that can be life‑threatening.

When prescribing Isoptin Retard, clinicians should consider several precautionary measures to minimize risk. - Assess cardiac function: evaluate baseline heart rate and conduction before initiation. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Review concomitant drugs: avoid combinations that may exacerbate bradycardia or AV block. - Adjust in hepatic impairment: dose may need reduction in patients with liver disease. - Caution in heart failure: use only if benefits outweigh risk of worsening symptoms. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture.

Verapamil interacts with several medicines; awareness of the interaction level guides clinical management.

Major Interactions (Avoid): - Beta‑blockers: combined effect can cause severe bradycardia or AV block. - Digoxin: increased serum digoxin levels, raising risk of toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): markedly raise verapamil concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, diuretics): additive blood‑pressure lowering effect. - Statins metabolized by CYP3A4 (e.g., simvastatin, atorvastatin): may increase statin exposure. - Antidiabetic agents (e.g., insulin, sulfonylureas): enhanced hypoglycaemic effect. - Rifampin: may reduce verapamil levels, decreasing efficacy.